Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors

A retrospective review of 626 patients with multifocal papillary thyroid carcinoma (PTC) including 147 patients (23.5%) with multifocal papillary thyroid microcarcinoma (PTMC) from a total of 2,536 patients with PTC who visited the Chang Gung Medical Center in Linkou, Taiwan, was performed. A compar...

Full description

Saved in:
Bibliographic Details
Main Authors: Soh-Ching Ng, Sheng-Fong Kuo, Szu-Tah Chen, Chuen Hsueh, Bie-Yu Huang, Jen-Der Lin
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2017/4208178
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549319703527424
author Soh-Ching Ng
Sheng-Fong Kuo
Szu-Tah Chen
Chuen Hsueh
Bie-Yu Huang
Jen-Der Lin
author_facet Soh-Ching Ng
Sheng-Fong Kuo
Szu-Tah Chen
Chuen Hsueh
Bie-Yu Huang
Jen-Der Lin
author_sort Soh-Ching Ng
collection DOAJ
description A retrospective review of 626 patients with multifocal papillary thyroid carcinoma (PTC) including 147 patients (23.5%) with multifocal papillary thyroid microcarcinoma (PTMC) from a total of 2,536 patients with PTC who visited the Chang Gung Medical Center in Linkou, Taiwan, was performed. A comparison of the clinical features between 626 multifocal and 1,910 solitary PTC cases showed that patients in the multifocal PTC group were older and had a smaller mean tumor size, a more advanced tumor-node-metastasis (TNM) stage, and a higher percentage of nonremission status compared to patients in the solitary PTC group. Of the 626 patients with multifocal PTC, the group with larger tumors showed a more advanced TNM stage, a higher percentage of lymph node metastasis and soft tissue invasion, and a higher nonremission rate compared to the multifocal PTMC group. Of the 626 patients with multifocal PTC, 25 patients (4%) died during a mean follow-up period of 7.1 ± 5.3 years. Kaplan-Meier survival curves showed a significantly lower survival rate associated with multifocal PTMC compared to that with solitary PTMC.
format Article
id doaj-art-968d942b2a094c0aaf556ec9643335c7
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-968d942b2a094c0aaf556ec9643335c72025-02-03T06:11:40ZengWileyInternational Journal of Endocrinology1687-83371687-83452017-01-01201710.1155/2017/42081784208178Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger TumorsSoh-Ching Ng0Sheng-Fong Kuo1Szu-Tah Chen2Chuen Hsueh3Bie-Yu Huang4Jen-Der Lin5Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung, TaiwanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung, TaiwanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University, Keelung, TaiwanDepartment of Pathology, Chang Gung Memorial Hospital and Chang Gung University, Keelung, TaiwanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung, TaiwanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University, Keelung, TaiwanA retrospective review of 626 patients with multifocal papillary thyroid carcinoma (PTC) including 147 patients (23.5%) with multifocal papillary thyroid microcarcinoma (PTMC) from a total of 2,536 patients with PTC who visited the Chang Gung Medical Center in Linkou, Taiwan, was performed. A comparison of the clinical features between 626 multifocal and 1,910 solitary PTC cases showed that patients in the multifocal PTC group were older and had a smaller mean tumor size, a more advanced tumor-node-metastasis (TNM) stage, and a higher percentage of nonremission status compared to patients in the solitary PTC group. Of the 626 patients with multifocal PTC, the group with larger tumors showed a more advanced TNM stage, a higher percentage of lymph node metastasis and soft tissue invasion, and a higher nonremission rate compared to the multifocal PTMC group. Of the 626 patients with multifocal PTC, 25 patients (4%) died during a mean follow-up period of 7.1 ± 5.3 years. Kaplan-Meier survival curves showed a significantly lower survival rate associated with multifocal PTMC compared to that with solitary PTMC.http://dx.doi.org/10.1155/2017/4208178
spellingShingle Soh-Ching Ng
Sheng-Fong Kuo
Szu-Tah Chen
Chuen Hsueh
Bie-Yu Huang
Jen-Der Lin
Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors
International Journal of Endocrinology
title Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors
title_full Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors
title_fullStr Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors
title_full_unstemmed Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors
title_short Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors
title_sort therapeutic outcomes of patients with multifocal papillary thyroid microcarcinomas and larger tumors
url http://dx.doi.org/10.1155/2017/4208178
work_keys_str_mv AT sohchingng therapeuticoutcomesofpatientswithmultifocalpapillarythyroidmicrocarcinomasandlargertumors
AT shengfongkuo therapeuticoutcomesofpatientswithmultifocalpapillarythyroidmicrocarcinomasandlargertumors
AT szutahchen therapeuticoutcomesofpatientswithmultifocalpapillarythyroidmicrocarcinomasandlargertumors
AT chuenhsueh therapeuticoutcomesofpatientswithmultifocalpapillarythyroidmicrocarcinomasandlargertumors
AT bieyuhuang therapeuticoutcomesofpatientswithmultifocalpapillarythyroidmicrocarcinomasandlargertumors
AT jenderlin therapeuticoutcomesofpatientswithmultifocalpapillarythyroidmicrocarcinomasandlargertumors